O. Hinschberger

1.9k total citations
17 papers, 229 citations indexed

About

O. Hinschberger is a scholar working on Neurology, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, O. Hinschberger has authored 17 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 4 papers in Infectious Diseases and 4 papers in Pathology and Forensic Medicine. Recurrent topics in O. Hinschberger's work include COVID-19 Clinical Research Studies (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and COVID-19 and healthcare impacts (3 papers). O. Hinschberger is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Inflammatory Myopathies and Dermatomyositis (3 papers) and COVID-19 and healthcare impacts (3 papers). O. Hinschberger collaborates with scholars based in France, United States and Morocco. O. Hinschberger's co-authors include Jean Sibilia, Charlotte Kaeuffer, Yves Allenbach, François Danion, Olivier Benvéniste, Floriane Gallais, Loïc Kassègne, Valentin Greigert, Alain Meyer and Joy Mootien and has published in prestigious journals such as Neurology, Arthritis Research & Therapy and Eurosurveillance.

In The Last Decade

O. Hinschberger

13 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Hinschberger France 9 77 71 49 46 44 17 229
P Müller Netherlands 10 63 0.8× 29 0.4× 70 1.4× 87 1.9× 55 1.3× 43 334
Jesus D. Gonzalez‐Lugo United States 7 30 0.4× 162 2.3× 79 1.6× 29 0.6× 29 0.7× 15 260
Raphaël Lhote France 11 76 1.0× 58 0.8× 33 0.7× 116 2.5× 53 1.2× 25 372
Matheus Vieira France 9 26 0.3× 105 1.5× 40 0.8× 65 1.4× 35 0.8× 18 251
Nirmalya Roy Moulik India 12 36 0.5× 37 0.5× 14 0.3× 54 1.2× 36 0.8× 57 385
Yangyuna Yang United States 10 62 0.8× 74 1.0× 32 0.7× 160 3.5× 37 0.8× 24 325
Andrea P. Espejo Freire United States 6 43 0.6× 119 1.7× 62 1.3× 14 0.3× 17 0.4× 20 249
Elrazi Ali Qatar 10 29 0.4× 67 0.9× 16 0.3× 28 0.6× 25 0.6× 57 294
Hugo Gale United Kingdom 2 69 0.9× 57 0.8× 20 0.4× 25 0.5× 14 0.3× 2 203
Gloria Pérez‐Rus Spain 7 17 0.2× 80 1.1× 37 0.8× 26 0.6× 19 0.4× 14 214

Countries citing papers authored by O. Hinschberger

Since Specialization
Citations

This map shows the geographic impact of O. Hinschberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Hinschberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Hinschberger more than expected).

Fields of papers citing papers by O. Hinschberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Hinschberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Hinschberger. The network helps show where O. Hinschberger may publish in the future.

Co-authorship network of co-authors of O. Hinschberger

This figure shows the co-authorship network connecting the top 25 collaborators of O. Hinschberger. A scholar is included among the top collaborators of O. Hinschberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Hinschberger. O. Hinschberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Martínez, Carmen, et al.. (2023). Une alpha thalassémie acquise chez un patient de 86 ans avec un syndrome myélodysplasique. La Revue de Médecine Interne. 44(2). 89–91.
2.
Messer, Laurent, M. Ardizzone, Thomas Gille, et al.. (2022). Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study. Lupus Science & Medicine. 9(1). e000700–e000700. 18 indexed citations
3.
Michel, Pierre, et al.. (2020). Systematic duplex ultrasound screening in conventional units for COVID-19 patients with follow-up of 5 days. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(4). 853–858. 9 indexed citations
4.
Kaeuffer, Charlotte, Thibaut Fabacher, Joy Mootien, et al.. (2020). Risk Factors Associated with Severe COVID-19 in Eastern France: Analysis of 1045 Cases. SSRN Electronic Journal. 3 indexed citations
5.
Kaeuffer, Charlotte, Thibaut Fabacher, Yvon Ruch, et al.. (2020). Caractéristiques cliniques et facteurs de risque associés aux formes sévères de COVID-19 : analyse prospective multicentrique de 1045 cas. Médecine et Maladies Infectieuses. 50(6). S27–S27.
6.
Kaeuffer, Charlotte, Thibaut Fabacher, Joy Mootien, et al.. (2020). Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Eurosurveillance. 25(48). 81 indexed citations
7.
Dieudonné, Yannick, Yves Allenbach, Olivier Benvéniste, et al.. (2019). Granulomatosis-associated myositis. Neurology. 94(9). e910–e920. 20 indexed citations
8.
Herbrecht, Raoul, Mario Ojeda‐Uribe, Daniel Kientz, et al.. (2018). Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura. Vox Sanguinis. 113(5). 459–467. 10 indexed citations
9.
Ojeda‐Uribe, Mario, O. Hinschberger, Jean‐Claude Eisenmann, et al.. (2015). Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate. Journal of Oncology Pharmacy Practice. 22(2). 361–370. 12 indexed citations
10.
Drouot, Laurent, Yves Allenbach, F. Jouen, et al.. (2014). Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. Arthritis Research & Therapy. 16(1). R39–R39. 55 indexed citations
11.
Hinschberger, O., et al.. (2013). Myopathie nécrosante auto-immune associée aux anticorps anti-hydroxy-méthyl-glutaryl-coenzyme A réductase. La Revue de Médecine Interne. 35(8). 546–549. 3 indexed citations
12.
Kieffer, P., et al.. (2013). Efficacité clinique et biologique du tocilizumab au cours de la maladie de Horton : à propos de trois observations et revue de la littérature. La Revue de Médecine Interne. 35(1). 56–59. 8 indexed citations
13.
Hinschberger, O., et al.. (2012). Paralysie périodique hypokaliémique : à propos d’un cas. Annales françaises de médecine d’urgence. 2(4). 277–279.
14.
Hinschberger, O., et al.. (2011). Traitement chirurgical de la maladie de Wegener. La Revue de Médecine Interne. 32. S149–S150. 1 indexed citations
15.
Hinschberger, O., et al.. (2011). Le syndrome de Melkersson-Rosenthal : à propos de 16 cas. La Revue de Médecine Interne. 32. S92–S92. 1 indexed citations
16.
Hinschberger, O., et al.. (2010). Syndrome de Gitelman acquis au cours d’un syndrome de Gougerot-Sjögren associé à une sclérodermie. La Revue de Médecine Interne. 32(8). e96–e98. 8 indexed citations
17.
Hinschberger, O., et al.. (2010). Sidérose superficielle du système nerveux central : à propos d’un cas. La Revue de Médecine Interne. 31. S178–S179.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Müller Breakdown of academic impact, for papers by Jesus D. Gonzalez‐Lugo Breakdown of academic impact, for papers by Raphaël Lhote Breakdown of academic impact, for papers by Matheus Vieira Breakdown of academic impact, for papers by Nirmalya Roy Moulik Breakdown of academic impact, for papers by Yangyuna Yang Breakdown of academic impact, for papers by Andrea P. Espejo Freire Breakdown of academic impact, for papers by Elrazi Ali Breakdown of academic impact, for papers by Hugo Gale Breakdown of academic impact, for papers by Gloria Pérez‐Rus
Rankless by CCL
2026